Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients.

Christophe CamusMélanie PoinotCharlotte PronierMichel RayarAnne Le NeillonMarianne LatournerieGisèle LagathuMatthieu Revest

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2024)

We reported more CMV DNAemias and ganciclovir-resistant CMV events with PS. The cost of the PS strategy was higher.

Keyphrases